MicroRNA-155 downregulation promotes cell cycle arrest and apoptosis in diffuse large B-cell lymphoma

Oncology Research

Volumn 24, Issue 6, 2016, Pages 415-427

  Zhu, Fu Qiang ^a   Zeng, Li ^b   Tang, Na ^a   Tang, Ya Ping ^c   Zhou, Bo Ping ^a   Li, Fang Fang ^a   Wu, Wei Gang ^a   Zeng, Xiao Bing ^a   Peng, Shu Song ^a  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^c Maternity and Child Health Care Hospital of Shenzhen   (China)

Author keywords

Apoptosis; Cell cycle; Lymphoma; MicroRNA 155 (miR 155); Transforming growth factor b receptor 2 (TGFBR2)

Indexed keywords

CASPASE 3; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA 155; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR NECROSIS FACTOR; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL LINE; DIFFUSE LARGE B CELL LYMPHOMA; GENE EXPRESSION REGULATION; GENETICS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE CHECKPOINTS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; RESTING PHASE, CELL CYCLE;

EID: 84992640373     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504016X14685034103473     Document Type: Article

References (36)

1. Campo, E.; Swerdlow, S. H.; Harris, N. L.; Pileri, S.; Stein, H.; Jaffe, E. S. The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications. Blood 117: 5019-5032; 2011.
2. Coiffier, B. Diffuse large cell lymphoma. Curr. Opin. Oncol. 13: 325-334; 2001.
3. Lossos, I. S.; Morgensztern, D. Prognostic biomarkers in diffuse large B-cell lymphoma. J. Clin. Oncol. 24: 995-1007; 2006.
4. Wilson, W. H.; Dunleavy, K.; Pittaluga, S.; Hegde, U.; Grant, N.; Steinberg, S. M.; Raffeld, M.; Gutierrez, M.; Chabner, B. A.; Staudt, L.; Jaffe, E. S.; Janik, J. E. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J. Clin. Oncol. 26: 2717-2124; 2008.
5. Uddin, S.; Hussain, A. R.; Siraj, A. K.; Manogaran, P. S.; Al-Jomah, N. A.; Moorji, A.; Atizado, V.; Al-Dayel, F.; Belgaumi, A.; El-Solh, H.; Ezzat, A.; Bavi, P.; Al-Kuraya, K. S. Role of phosphatidylinositol 3-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178-4186; 2006.
6. Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233; 2009.
7. Di Leva, G.; Croce, C. M. Roles of small RNAs in tumor formation. Trends Mol. Med. 16: 257-267; 2010.
8. Zhang, B.; Pan, X.; Cobb, G. P.; Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302: 1-12; 2007.
9. Malumbres, R.; Sarosiek, K. A.; Cubedo, E.; Ruiz, J. W.; Jiang, X.; Gascoyne, R. D.; Tibshirani, R.; Lossos, I. S. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764; 2009.
10. Roehle, A.; Hoefig, K. P.; Repsilber, D.; Thorns, C.; Ziepert, M.; Wesche, K. O.; Thiere, M.; Loeffler, M.; Klapper, W.; Pfreundschuh, M. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol. 142: 732-744; 2008.
11. Li, J.; Wan, Y.; Ji, Q.; Fang, Y.; Wu, Y. The role of microRNAs in B-cell development and function. Cell. Mol. Immunol. 10: 107-112; 2013.
12. Metzler, M.; Wilda, M.; Busch, K.; Viehmann, S.; Borkhardt, A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39: 167-169; 2004.
13. Kluiver, J.; Poppema, S.; de Jong, D.; Blokzijl, T.; Harms, G.; Jacobs, S.; Kroesen, B. J.; van den Berg, A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207: 243-249; 2005.
14. Ma, X.; Buscaglia, L. E. B.; Barker, J. R.; Li, Y. MicroRNAs in NF-κB signaling. J. Mol. Cell Biol. 3: 159-166; 2011.
15. Costinean, S.; Zanesi, N.; Pekarsky, Y.; Tili, E.; Volinia, S.; Heerema, N.; Croce, C. M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103: 7024-7029; 2006.
16. Kong, W.; He, L.; Coppola, M.; Guo, J.; Esposito, N. N.; Coppola, D.; Cheng, J. Q. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J. Biol. Chem. 285: 17869-17879; 2010.
17. Wang, P.; Hou, J.; Lin, L.; Wang, C.; Liu, X.; Li, D.; Ma, F.; Wang, Z.; Cao, X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 185: 6226-6233; 2010.
18. Kong, W.; Yang, H.; He, L.; Zhao, J. J.; Coppola, D.; Dalton, W. S.; Cheng, J. Q. MicroRNA-155 is regulated by the transforming growth factor b/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28: 6773-6784; 2008.
19. Pedersen, I. M.; Otero, D.; Kao, E.; Miletic, A. V.; Hother, C.; Ralfkiaer, E.; Rickert, R. C.; Gronbaek, K.; David, M. Onco-miR-155 targets SHIP1 to promote TNFa-dependent growth of B cell lymphomas. EMBO Mol. Med. 1: 288-295; 2009.
20. Willenbrock, K.; Kuppers, R.; Renn C.; Brune, V.; Eckerle, S.; Weidmann, E.; Brauninger, A.; Hansmann, M. L. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91: 596-604; 2006.
21. Rai, D.; Kim, S. W.; McKeller, M. R.; Dahia, P. L.; Aguiar, R. C. Targeting of SMAD5 links microRNA-155 to the TGF-b pathway and lymphomagenesis. Proc. Natl. Acad. Sci. USA 107: 3111-3116; 2010.
22. Schneider, C.; Setty, M.; Holmes, A. B.; Maute, R. L.; Leslie, C. S.; Mussolin, L.; Rosolen, A.; Dalla-Favera, R.; Basso, K. microRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas. Proc. Natl. Acad. Sci. USA 111: 8185-8190; 2014.
23. Craig, V.; Tzankov, A.; Flori, M.; Schmid, C.; Bader, A.; Mler, A. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 26: 2421-2424; 2012.
24. Tomayko, M. M.; Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24: 148-154; 1989.
25. Gironella, M.; Seux, M.; Xie, M. J.; Cano, C.; Tomasini, R.; Gommeaux, J.; Garcia, S.; Nowak, J.; Yeung, M. L.; Jeang, K. T. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 104: 16170-16175; 2007.
26. Yang, M.; Shen, H.; Qiu, C.; Ni, Y.; Wang, L.; Dong, W.; Liao, Y.; Du, J. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur. J. Cancer 49: 604-615; 2013.
27. Lawrie, C. H.; Gal, S.; Dunlop, H. M.; Pushkaran, B.; Liggins, A. P.; Pulford, K.; Banham, A. H.; Pezzella, F.; Boultwood, J.; Wainscoat, J. S. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141: 672-675; 2008.
28. Linnstaedt, S. D.; Gottwein, E.; Skalsky, R. L.; Luftig, M. A.; Cullen, B. R. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84: 11670-11678; 2010.
29. Elangovan, S.; Hsieh, T. C.; Wu, J. M. Growth inhibition of human MDA-MB-231 breast cancer cells by d-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res. 28: 2641-2647; 2008.
30. Balmanno, K.; Cook, S. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 16: 368-377; 2009.
31. Lech-Maranda, E.; Bienvenu, J.; Broussais-Guillaumot, F.; Warzocha, K.; Michallet, A. S.; Robak, T.; Coiffier, B.; Salles, G. Plasma TNF-A and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index. Arch. Immunol. Ther. Exp. 58: 131-141; 2010.
32. Tili, E.; Michaille, J. J.; Cimino, A.; Costinean, S.; Dumitru, C. D.; Adair, B.; Fabbri, M.; Alder, H.; Liu, C. G.; Calin, G. A. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-A stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089; 2007.
33. Massague, J.; Blain, S. W.; Lo, R. S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309; 2000.
34. Mamiya, T.; Yamazaki, K.; Masugi, Y.; Mori, T.; Effendi, K.; Du, W.; Hibi, T.; Tanabe, M.; Ueda, M.; Takayama, T. Reduced transforming growth factor-b receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab. Invest. 90: 1339-1345; 2010.
35. Mishra, S.; Deng, J. J.; Gowda, P. S.; Rao, M. K.; Lin, C. L.; Chen, C. L.; Huang, T.; Sun, L. Z. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene 33: 4097-4106; 2014.
36. Harazono, Y.; Muramatsu, T.; Endo, H.; Uzawa, N.; Kawano, T.; Harada, K.; Inazawa, J.; Kozaki, K. I. miR-655 is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One 8: E62757; 2013.